Wire Stories
453Vontobel continues multi-boutique expansion in North America
NEW YORK–(BUSINESS WIRE)–With growing demand from US and Canadian investors for systematic and fundamental investing, Vontobel has made available select strategies...
- 675
Seagen, Astellas and Merck Announce Results of Clinical Trial Investigating PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) and PADCEV as Monotherapy in First-Line Advanced Urothelial Cancer
– Results demonstrated a 64.5% confirmed objective response rate in patients treated with investigational combination of enfortumab vedotin and pembrolizumab – –...
- 516
AnHeart Therapeutics and NewG Lab Therapeutics Receive Orphan Drug Designation in Korea for Taletrectinib in ROS1-Positive Non-Small Cell Lung Cancer
NEW YORK & SEOUL, South Korea–(BUSINESS WIRE)–#BTD—AnHeart Therapeutics and NewG Lab Therapeutics, a subsidiary of NewG Lab Pharma, announced that the Ministry...
- 591
Bacardi Announces New Leadership for Its Global Travel Retail Business
HAMILTON, Bermuda–(BUSINESS WIRE)–#BacardiLife–Bacardi announces a change at the top of its global travel retail business (GTR), effective January 2023. The current Managing...
- 458
Vista Gold Corp. Provides Update on Strategic Process
DENVER–(BUSINESS WIRE)–Vista Gold Corp. (NYSE American and TSX: VGZ) (“Vista” or the “Company”) today announced the following update regarding the Company’s process...
- 495
LESSENGERS Demonstrates 800G QSFP-DD and 400G QSFP112 Optical Transceivers
BASEL, Switzerland–(BUSINESS WIRE)–LESSENGERS Inc. (“LESSENGERS”), an innovative optical interconnect solution provider, announced today, a live demonstration of polymer-wired 800G QSFP-DD and 400G...
- 487
India Over The Counter Drug Market to Grow at 7.85% Through 2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India Over The Counter Drug Market, By Product Type, By Route of Administration, By Dosage Form, By Distribution Channel, By...
- 582
J.P. Morgan to Acquire Renovite Technologies, Inc.
Acquisition of cloud-native payments technology firm to modernize infrastructure and create greater flexibility for the firm’s merchant acquiring capabilities globally NEW YORK...
- 549
Announcement for “Innovation for Cool Earth Forum 9th Annual Meeting (ICEF2022)”
The international conference to discuss innovation, the key to solving global warming with experts from industry, academia, and government from the world...
- 666
Cellusion and Celregen, a member of Fosun Pharma, Enter into Exclusive License Agreement of CLS001 for a Corneal Endothelial Cell Regenerative Therapy in the Greater China Region
Celregen Obtains the Exclusive Rights to Develop, Manufacturing and Commercialize CLS001 in Greater China Region; Cellusion Retains Other Regional Rights. The Deal...
